Published in J Med Virol on July 01, 1994
Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev (2000) 3.70
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26
A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol (2000) 0.99
Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation. J Clin Microbiol (1996) 0.85
Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia. Dig Dis Sci (2002) 0.83
Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus. Dig Dis Sci (1998) 0.81
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A (1991) 7.13
Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol (1987) 6.16
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
Guidelines for the management of hemophilia. Haemophilia (2012) 5.16
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature (1986) 4.81
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet (1993) 4.51
Homology requirements for recombination in Escherichia coli. Proc Natl Acad Sci U S A (1985) 4.46
A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res (1997) 4.40
Sexual transmission of hepatitis C virus. Lancet (1993) 4.27
Hepatitis C virus six years on. Lancet (1994) 4.09
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Paying for blood donations: still a risk? Vox Sang (2002) 3.67
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
Isolation of the yeast calmodulin gene: calmodulin is an essential protein. Cell (1986) 3.17
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res (1986) 3.11
Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing. DNA (1984) 2.96
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. Vox Sang (2005) 2.77
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74
Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science (1985) 2.72
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A (1992) 2.56
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J (1985) 2.47
Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates. Lancet (1992) 2.44
Early detection of antibodies to HIV-1 by third-generation assays. Lancet (1992) 2.18
Construction and evaluation of an instrument for the automated synthesis of oligodeoxyribonucleotides. DNA (1984) 2.07
The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell (1986) 2.06
Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C. Ann Intern Med (1996) 2.05
The growing number of hemophilia registries: Quantity vs. quality. Clin Pharmacol Ther (2015) 2.04
Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus. Lancet (1986) 2.04
Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet (1979) 2.03
Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol (1994) 2.02
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost (2006) 2.01
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol (1995) 2.00
Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J (Clin Res Ed) (1983) 1.86
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol (1991) 1.83
Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion (1992) 1.82
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet (1989) 1.82
Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast. Proc Natl Acad Sci U S A (1983) 1.81
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis (2005) 1.80
The nucleotide sequence of the tetracycline resistance determinant tetM from Ureaplasma urealyticum. Nucleic Acids Res (1988) 1.77
Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis (1991) 1.77
Primary structure of the Streptomyces R61 extracellular DD-peptidase. 1. Cloning into Streptomyces lividans and nucleotide sequence of the gene. Eur J Biochem (1987) 1.77
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem (1995) 1.69
Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A. J Thromb Haemost (2007) 1.67
The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue. J Virol Methods (1994) 1.62
Cloned human snRNP proteins B and B' differ only in their carboxy-terminal part. EMBO J (1989) 1.59
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. Haemophilia (2005) 1.54
Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol (1992) 1.49
Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice. J Thromb Haemost (2008) 1.48
Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology (1995) 1.47
Hepatitis E in The Netherlands: imported and endemic. Lancet (1993) 1.45
Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol (2000) 1.45
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci (1997) 1.44
Forks and combs and DNA: the synthesis of branched oligodeoxyribonucleotides. Nucleic Acids Res (1989) 1.44
Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection. Vox Sang (1989) 1.43
Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS (1993) 1.42
Cord blood banking. Vox Sang (2008) 1.41
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41
Homology of the TetM with translational elongation factors: implications for potential modes of tetM-conferred tetracycline resistance. Nucleic Acids Res (1988) 1.40
Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol (1993) 1.40
Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up. Haemophilia (2007) 1.40
[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Ned Tijdschr Geneeskd (2005) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion (1998) 1.39
A case-control study on the psychological aspects and coping in haemophilic patients. Haemophilia (2004) 1.39
New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results. Transfusion (1997) 1.38